MedTrace Logo

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

NCT00666432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2021-05-03

No results posted yet for this study

Summary

Briefly, this multisite study is designed to identify endophenotypes (i.e., heritable biomarkers) associated with either schizophrenia or bipolar disorder alone, or both together. The subsequent genetic analyses will search genomic loci and candidate genes associated with each of the independent endophenotypes. This is a five site study that is slotted for NIMH funding.

Conditions

Interventions

OTHER

This is an observational study model that is family based

This is an observational study model that is family based

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Liyi E Hong, M.D. · University of Maryland, Baltimore

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2012-09-30
Completion
2019-11-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666432 on ClinicalTrials.gov